HomeNewsTrendsHealthOmicron: Urgent need to scale-up public health, social measures to curtail spread, says WHO

Omicron: Urgent need to scale-up public health, social measures to curtail spread, says WHO

Countries can and must prevent the spread of Omicron with proven health and social measures, Regional Director, WHO South-East Asia Region, Poonam Khetrapal Singh said.

December 18, 2021 / 12:29 IST
Story continues below Advertisement
Emerging data from South Africa suggests increased risk of re-infection with Omicron, said Regional Director, WHO South-East Asia Region, Poonam Khetrapal Singh. (Representative image: AP)
Emerging data from South Africa suggests increased risk of re-infection with Omicron, said Regional Director, WHO South-East Asia Region, Poonam Khetrapal Singh. (Representative image: AP)

With seven countries in the South-East Asia Region confirming cases of new COVID-19 variant Omicron, the World Health Organization on December 18 stressed on urgent scale-up of public health and social measures to curtail its further spread. Countries can and must prevent the spread of Omicron with proven health and social measures, Regional Director, WHO South-East Asia Region, Poonam Khetrapal Singh said.

"Our focus must continue to be to protect the least protected and those at high risk, she said in a statement.

Story continues below Advertisement

The overall threat posed by Omicron largely depends on three key questions - its transmissibility; how well the vaccines and prior SARS-CoV-2 infection protect against it, and how virulent the variant is as compared to other variants.

"From what we know so far, Omicron appears to spread faster than the Delta variant which has been attributed to the surge in cases across the world in the last several months," Singh said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show